2009•Medical Journal of West ChinaRequires access

Therapeutic effect of magnesium isoglyeyrrhizinate on chronic hepatitis B

Hu Jian

Open publisher page 0 citations

Abstract

Objective To observe the therapeutic effects and drug safety of magnesium isoglyeyrrhizinate on chronic hepatitis B.Methods 178 patients of chronic hepatitis B were randomly divided into 3 groups,including high dose of magnesium isoglycyrrhizinate group(200mg of intravenous drop infusion administration),low dose of magnesium isoglycyrrhizinate group(100mg of intravenous drop infusion administration) and diammonium glycyrrhizinate group(150mg of intravenous drop infusion administration).Results The improvement rates of symptom,clinical signs and liver function of magnesium isoglycyrrhizinate administrations was more obvious than that of diammonium glycyrrhizinate group.There was no serious adverse effect after treatment.Conclusion The therapeutic effect of magnesium isoglycyrrhizinate was better than that of diammonium glycyrrhizinate for chronic hepatitis B.

About this research paper

What this paper is about

Objective To observe the therapeutic effects and drug safety of magnesium isoglyeyrrhizinate on chronic hepatitis B.Methods 178 patients of chronic hepatitis B were randomly divided into 3 groups,including high dose of magnesium isoglycyrrhizinate group(200mg of intravenous drop infusion administration),low dose of magnesium isoglycyrrhizinate group(100mg of intravenous drop infusion administration) and diammonium glycyrrhizinate group(150mg of intravenous drop infusion administration).Results The improvement rates of symptom,clinical signs and liver function of magnesium isoglycyrrhizinate administrations was more obvious than that of diammonium glycyrrhizinate group.There was no serious adverse effect after treatment.Conclusion The therapeutic effect of magnesium isoglycyrrhizinate was better than that of diammonium glycyrrhizinate for chronic hepatitis B.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the therapeutic effects and drug safety of magnesium isoglyeyrrhizinate on chronic hepatitis B.Methods 178 patients of chronic hepatitis B were randomly divided into 3 groups,including high dose of magnesium isoglycyrrhizinate group(200mg of intravenous drop infusion administration),low dose of magnesium isoglycyrrhizinate group(100mg of intravenous drop infusion administration) and diammonium glycyrrhizinate group(150mg of intravenous drop infusion administration).Results The improvement rates of symptom,clinical signs and liver function of magnesium isoglycyrrhizinate administrations was more obvious than that of diammonium glycyrrhizinate group.There was no serious adverse effect after treatment.Conclusion The therapeutic effect of magnesium isoglycyrrhizinate was better than that of diammonium glycyrrhizinate for chronic hepatitis B.

Key concepts: Medicine, Therapeutic effect, Chronic hepatitis, Magnesium, Adverse effect, Gastroenterology, Hepatitis, Liver function

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic effect of magnesium isoglyeyrrhizinate on chronic hepatitis B — Research Paper | ScholarLens